Showing results (291-300 of 687) with videos related to
Sort By:
Pageof 69
Toxicology Letters|November 1, 1992
Ganglioside GM1 counteracts the enhancing effects of subacute toluene exposure on apomorphine-induced locomotor activityG von Euler, S O Ogren, K Fuxe, et al.Biochemical and Biophysical Research Communications|July 25, 2000
Functional interaction of the immunosuppressant mizoribine with the 14-3-3 proteinS Takahashi, H Wakui, J A Gustafsson, et al.Developmental Neuroscience|December 9, 2000
Maternal high n-6 polyunsaturated fatty acid intake during pregnancy increases voluntary alcohol intake and hypothalamic estrogen receptor alpha and beta levels among female offspringA Cabanes, S de Assis, J A Gustafsson, et al.Molecular Endocrinology (Baltimore, Md.)|November 1, 1996
Identification of single amino acid substitutions of Cys-736 that affect the steroid-binding affinity and specificity of the glucocorticoid receptor using phenotypic screening in yeastU Lind, J Carlstedt-Duke, J A Gustafsson, et al.Cancer Letters|February 27, 1996
Expression of the c-jun, jun-B, ets-2 and liver regeneration factor-1 (LRF-1) genes during promotion and progression of rat liver carcinogenesis in the resistant hepatocyte modelD Z Liao, A Blanck, J A Gustafsson, et al.Neuroreport|December 20, 1994
Localization of the peroxisome proliferator-activated receptor in the brainT Kainu, A C Wikström, J A Gustafsson, et al.Endocrinology|May 1, 1995
Estrogen target tissue determines alternative promoter utilization of the human estrogen receptor gene in osteoblasts and tumor cell linesK Grandien, M Bäckdahl, O Ljunggren, et al.European Journal of Biochemistry|February 15, 1977
Interactions of corticosterone, 5alpha-dihydrocorticosterone and dexamethasone with proteins in rat-liver cytosolJ Carlstedt-Duke, J A Gustafsson, S A Gustafsson, et al.Carcinogenesis|July 1, 1984
Short-term bioassays of nitro derivatives of benzo[a]pyrene and peryleneG Löfroth, R Toftgård, L Nilsson, et al.Neuroscience Letters|July 17, 2009
On the catecholamine control of growth hormone regulation. Evidence for discrete changes in dopamine and noradrenaline turnover following growth hormone administrationK Andersson, K Fuxe, P Eneroth, et al.Pageof 69